CDS WG Agenda 2018-01

From HL7Wiki
Jump to: navigation, search

Clinical Decision Support Work Group Agenda Jan-Feb 2018 (1/27-2/2) Work Group Meeting, New Orleans, Louisiana


Primary CDS Work Group meeting will be from Tue and Wed


Attendance tracking

Please use: https://goo.gl/TbW8MM


Other Work Groups' agendas

http://wiki.hl7.org/index.php?title=WGM_information


Discussion Items pending allocation of time



Saturday and Sunday: FHIR Connectathon

There will be a track on CDS and eCQM, including work with the unification with CDS Hooks for CDS services.


Monday: no official meetings

Arden Syntax meeting Monday rather than Tuesday

Q3 - CQI representatives invited by O&O re: overlapping resources. CDS members may have interest.

Q4 - Representatives invited by FHIR Infrastructure to discuss FHIR Workflow (multiple WGs invited)


Tues Q1: Joint with Arden (CDS hosts)

- Brief overview of WG activities

- Agenda review and update as needed

- Update on vMR v2 ballot

- Future direction for detail models

- (Tentative) WG health/administration issues (e.g., updating PSS target dates, DMP update)

- (Tentative) PSSs and project planning


Tues Q1 (FYI): CQI will be discussing quality measures with DOD

- CDS members welcome to join


Tues Q2: CQI hosts CDS and FHIR Infrastructure reps (Kevin Shekleton requested; Isaac Vetter unavailable)

- Connect-a-thon updates

- CDS Hooks 1.0 specification GitHub comments review

- Infobutton on CDS Hooks -- Connect-a-Thon demo and updates

- Opioid CDS Hooks -- Connect-a-Thon demo and updates

- CDS Hooks Boston Children's IP issue update and May 2018 ballot approach -- submit NIB or wait until IP issues resolved? If submit NIB, pull before ballot announcement if IP issue not resolved?


Tues Q3: CDS hosts CQI and FHIR Infrastructure reps (Kevin Shekleton requested; Isaac Vetter unavailable) (3rd floor, St. James)

- Clinical Reasoning and QICore ballot reconciliation; CQL STU comments reconciliation

- Future of QICore/modeling activities and vendor support for required FHIR profiles

- (tentative) discussion with PHER representatives on immunization CDS

- (as time allows) additional FHIR tracker item reconciliation and FHIR goals


Tues Q4: Regular meeting (light quarter, may adjourn early) (2nd floor, Marlborough A)

- Clinical Reasoning ballot reconciliation (only items that are CDS-specific)

- Overflow: WG health/administration issues (e.g., updating PSS target dates)

- Overflow: PSSs and project planning

- Open Call for Agenda Items / Information Sharing (e.g., Univ. of Utah would be happy to share its work on productions uses of FHIR, CDS Hooks, and SMART on FHIR for CDS)

- ITS discussing FHIRPath (Bryn attending; others welcome)


Wed Q1: Joint with CQI and CIMI, hosted by CQI (St. James, 3rd floor)

- CDS KNART project -- status update

- ELTSS project (electronic long term services and analysis)

- Future of QICore/modeling activities and intersection with CIMI, including relationship to FHIR profiles


Wed Q2: Joint with CQI (CQI hosts) Confirmed will also meet with Pharmacy (St. James, 3rd floor)

- Drug-drug interaction knowledge modeling with CQI and Pharmacy


Wed Q3 (Option 1): Joint with CQI (CDS hosts) (St. James, 3rd floor)

- QICore ballot reconciliation; CQL STU comments reconciliation

- Joint WG health/administration issues (e.g., updating PSS target dates)

- Joint PSSs and project planning


Wed Q3 (Option 2): Reps to join O&O on mutually important FHIR resources discussion

Joint meeting with FHIR-I, CDS, CQI, PCWG Topic: FHIR resources with joint interest


Wed Q4: Joint session hosting CQI and CIMI (likely half a session) (St. James, 3rd floor)

- CIMI for Quality

- Clinical Reasoning and QICore ballot reconciliation


Thurs Q1: No meeting

- Orders and Observations invites CDS WG representatives (updates from various WGs; overflow for Wed Q3)


Thurs Q3: No meeting

- Patient Care and PHER discussing adverse event / allergy modeling

Copyright © Health Level Seven International ® ALL RIGHTS RESERVED. The reproduction of this material in any form is strictly forbidden without the written permission of the publisher.